United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read General business news Landsec FY25 results: £393m profit, 6.4% ROE, £3bn shift to residential and retail assets Landsec posts £393M FY25 profit, eyes £3B asset shift to retail and residential. Analysts track ROE rebound, rental growth, and EPS outlook for FY26. byPallavi MadhirajuMay 18, 2025